Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
Blood
|
March 11, 2011
Low but sustained coagulation activation ameliorates glucose-induced podocyte apoptosis: protective effect of factor V Leiden in diabetic nephropathy
Hongjie Wang, Thati Madhusudhan, Tao He, et al.
Molecular Medicine (Cambridge, Mass.)
|
November 2, 2012
Targeting activation of specific NF-κB subunits prevents stress-dependent atherothrombotic gene expression
Zdenka Djuric, Muhammed Kashif, Thomas Fleming, et al.
Circulation
|
August 19, 2009
Hypercoagulability inhibits monocyte transendothelial migration through protease-activated receptor-1-, phospholipase-Cbeta-, phosphoinositide 3-kinase-, and nitric oxide-dependent signaling in monocytes and promotes plaque stability
Stefanie Seehaus, Khurrum Shahzad, Muhammed Kashif, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 26, 2012
Activated protein C ameliorates diabetic nephropathy by epigenetically inhibiting the redox enzyme p66Shc
Fabian Bock, Khurrum Shahzad, Hongjie Wang, et al.
Nature Medicine
|
November 6, 2007
Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis
Berend Isermann, Ilya A Vinnikov, Thati Madhusudhan, et al.
Blood
|
September 4, 2016
Maternal extracellular vesicles and platelets promote preeclampsia via inflammasome activation in trophoblasts
Shrey Kohli, Satish Ranjan, Juliane Hoffmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 2, 2022
Phase II Trial of Adjuvant Nivolumab Following Salvage Resection in Patients with Recurrent Squamous Cell Carcinoma of the Head and Neck
Jennifer L Leddon, Shuchi Gulati, Sulsal Haque, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 26, 2022
Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local-Regionally Advanced Head and Neck Squamous Cell Carcinoma
Trisha M Wise-Draper, Shuchi Gulati, Sarah Palackdharry, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
Blood
|
March 11, 2011
Low but sustained coagulation activation ameliorates glucose-induced podocyte apoptosis: protective effect of factor V Leiden in diabetic nephropathy
Hongjie Wang, Thati Madhusudhan, Tao He, et al.
Molecular Medicine (Cambridge, Mass.)
|
November 2, 2012
Targeting activation of specific NF-κB subunits prevents stress-dependent atherothrombotic gene expression
Zdenka Djuric, Muhammed Kashif, Thomas Fleming, et al.
Circulation
|
August 19, 2009
Hypercoagulability inhibits monocyte transendothelial migration through protease-activated receptor-1-, phospholipase-Cbeta-, phosphoinositide 3-kinase-, and nitric oxide-dependent signaling in monocytes and promotes plaque stability
Stefanie Seehaus, Khurrum Shahzad, Muhammed Kashif, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 26, 2012
Activated protein C ameliorates diabetic nephropathy by epigenetically inhibiting the redox enzyme p66Shc
Fabian Bock, Khurrum Shahzad, Hongjie Wang, et al.
Nature Medicine
|
November 6, 2007
Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis
Berend Isermann, Ilya A Vinnikov, Thati Madhusudhan, et al.
Blood
|
September 4, 2016
Maternal extracellular vesicles and platelets promote preeclampsia via inflammasome activation in trophoblasts
Shrey Kohli, Satish Ranjan, Juliane Hoffmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 2, 2022
Phase II Trial of Adjuvant Nivolumab Following Salvage Resection in Patients with Recurrent Squamous Cell Carcinoma of the Head and Neck
Jennifer L Leddon, Shuchi Gulati, Sulsal Haque, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 26, 2022
Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local-Regionally Advanced Head and Neck Squamous Cell Carcinoma
Trisha M Wise-Draper, Shuchi Gulati, Sarah Palackdharry, et al.
Page
of 2